Press: Celadon Pharmaceuticals highlighted in directors talk interview on Investing and Spring Budget Insights by Gervais Williams

Mar 20, 2023 | Celadon Pharmaceuticals

We are pleased to share with you some exciting news about our recent feature on DirectorsTalk, where Gervais Williams provides insights into the impact of the Spring budget on investing and highlights several companies, including Celadon Pharmaceuticals Plc. Gervais...

Celadon becomes first UK medical cannabis group to win right to sell in Britain

Mar 17, 2023 | Celadon Pharmaceuticals

Celadon Pharmaceuticals has become the first UK-based medical cannabis manufacturer to be granted a Home Office licence to sell its products in the UK since government reforms opened up the industry in 2018. The London-listed company can now pursue supply deals to...

A new leaf? The Cornish company trying to unlock secrets of cannabis

Feb 11, 2023 | Phytome

Rather than making products, Phytome alters the cultivation of the plants themselves in a bid to create new compounds. Elegantly refurbished farm buildings hardly merit a second look near the Cornish coast, but the CCTV cameras on stalks around the Trelonk estate hint...

Cornwall MP Cherilyn Mackrory visits Phytome Life Sciences

Feb 10, 2023 | Phytome

Cherilyn Mackrory, MP for Truro and Falmouth, visited on Friday 3 February Truro-based Phytome Life Sciences, a business conducting biopharmaceutical research to develop medicines from plants. Phytome Life Sciences is working in collaboration with the University of...

Glass Pharms supports NHS Health Economics Analysis

Jan 18, 2023 | Glass Pharms

Glass Pharms are supporting a Health Economics Analysis study conducted by the University of York that will examine the potential economic cost benefits if cannabis-based medicines were prescribed to chronic pain patients on the NHS. The research will include a...